The PI3K-AKT-mTOR and Ras-MAPK pathways have profound effects on cell survival in cholangiocarcinoma [25], and they have been identified as potential therapeutic targets in cancer treatment [26, 27]. This evidence concerns the gene MTOR and cholangiocarcinoma.